Starting from the 2024-25 academic session, all medical colleges in the country, both private and public, will mandatorily be rated and ranked. The move follows a Memorandum of Understanding (MoU) signed by the National Medical Commission (NMC) with the Quality Council of India (QCI) to rate medical institutions.

An MoU between the NMC, the medical education regulator, and the QCI was signed recently to this effect

Announcement – NMC

Common National Medical Register for all practitioners across country – Announcement by NMC

All registered medical practitioners across the country will now be covered under a common National Medical Register with each of them allotted a unique identification number, as per a gazette notification recently released by the National Medical Commission (NMC) titled “Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023”.

The notification also makes the passing of National Exit Test (NEXT) compulsory for both Indian and foreign medical graduates for the purpose of registration with the National Medical Register.

Under the latest notification, the national register will contain all the entries of the registered medical practitioners of all State registers maintained by the various State Medical Councils.

Further, this register will be made public on the official NMC website and will contain relevant information about a medical practitioner including registration number, name, father’s name, date of registration, place of working (name of hospital/institute), medical qualification including additional medical qualification, speciality, year of passing, university, name of the institute/university where qualification was obtained.

The notification explains that until such time that these regulations and appropriate sections are in force, licence to practise and prevailing system of registration shall continue.

Besides, the notification also notes down the process of renewal clearly noting that a licence to practise is valid only for five years, after which all doctors will have to apply for renewal to the State Medical Council.

The NMC has also laid down the process of registration of additional qualifications, renewal of licence to practise medicine, transfer of licence to practise, removal and restoration of registration, transitory provisions, denial of licence to practise, among others.

On denial of licence to practise, the notification says that if the application of a candidate for grant of licence to practise /for renewal is rejected by the State Medical Council on any ground, the applicant concerned may file an appeal to the Ethics and Medical Registration Board (EMRB) against the decision of the State medical Council, within 30 days of receipt of such decision.

The EMRB shall examine the appeal and in case the first appeal is rejected by the Board, the applicant may file a second appeal to the NMC, within a period of 60 days from receipt of communication from the EMRB. “The decision of the NMC shall be final,” said the notification.



Enrolment of Medical Colleges as ADR monitoring centers under PvPI

NMC Mandate Enrolment of Medical Colleges as ADR monitoring centers under PvPI

Aiming to uplift regulatory standards for the overall collection, analysis and monitoring of Adverse Drug Reactions (ADRs) from the Public, National Medical Commission (NMC) has directed all medical colleges, standalone PG Institutions to enrol themselves as Adverse Drug Reaction Monitoring Centers with the Indian Pharmacopoeia Commission (IPC) under the Pharmacovigilance Program of India (PvPI) at the earliest.

Indian Pharmacopoeia is functioning as the National Co-ordination Centre, Pharmacovigilance Programme of India to collect, analyse and monitor the adverse drug reactions from the Indian population to promote Patient Safety and Safeguard the health of patients by ensuring that the benefits of the use of medicines outweigh the risk associated with its use

The collected ADRs data is a significant source of evidence of recommendations of regulatory interventions regarding the safety of medicines to the Central Drugs Standard Control Organisation (CDSCO)       

In order to achieve the above objective, IPC has so far enrolled 652 Adverse Drug Monitoring Centres (AMCs).

In the 22 nd Meeting of the Governing Body of India Pharmacopoeia Commission held on 14.10.2022 under the chairmanship of the Secretary (HFW) it has been decided that all Medical colleges/ hospitals under the National Medical Commission should also be enrolled as AMCs with IPC.

Accordingly, all Medical colleges/hospitals under the National Medical Commission are directed to get themselves enrolled with Indian Pharmacopoeia Commission (IPC) as AMCs at the earliest.


Advisory from National Medical Commission

Advisory from National Medical Commission ( Administration Section )

National Medical Commission has issued an advisory note on 27th July 2022 to all Medical Colleges and Institutions to install cameras in their Institute premises at prescribed locations with the suggested specifications given in the advisory note.

Source link: https://www.nmc.org.in/MCIRest/open/getDocumentpath=/Documents/Public/Portal/LatestNews/20220727062249.pdf